首页|PON1基因在肝细胞癌中的表达及其对临床预后的意义和免疫浸润分析

PON1基因在肝细胞癌中的表达及其对临床预后的意义和免疫浸润分析

Expression of the PON1 gene in hepatocellular carcinoma and its significance for clinical prognosis and immune infiltration analysis

扫码查看
目的 探索人对氧磷酶-1(PON1)基因在肝细胞癌(HCC)的表达及其对临床预后的意义和免疫浸润分析.方法 首先使用在线数据库TIMER、HCCDB和Kaplan-Meier Plotter,获得HCC患者PON1的基因表达水平及预后价值.并收集2011年4月至2015年6月在广西医科大学附属肿瘤医院接受手术治疗的90例HCC患者的癌及癌旁肝组织,检测PON1基因表达水平,结合临床相关参数,采用Cox回归分析,筛选与肝癌患者预后有意义的参数并构建预后模型.最后进行相关性分析,评估免疫细胞浸润特征.结果 PON1的基因表达水平在HCC组织中均显著低于癌旁,且PON1低表达与HCC的预后不良相关(P<0.05).PON1 mRNA水平、BCLC分期、CNLC分期、T分期、微血管侵犯(MVI)数量、血管侵犯、血清AFP水平与HCC预后显著相关(P<0.05).BCLC分期、血清AFP、PON1 mRNA表达水平是HCC患者预后的独立危险因素.联合三个指标建立的1、2、3年总生存期预后列线图模型具有良好的预测性能及临床实用价值(C-index=0.757).免疫浸润分析显示,PON1与HCC中多种免疫浸润细胞显著相关(P<0.05).结论 低表达的PON1可作为肝癌患者预后不良的潜在标志物,PON1联合血清AFP水平、BCLC分期构建的预测模型,可有效预测肝癌患者预后.
Objective To explore the expression of the paraoxonase-1(PON1)gene in hepatocellular carcinoma(HCC)and its clinical prognostic significance,as well as immune infiltration analysis.Methods Firstly,the gene ex-pression levels and prognostic value of PON1 in HCC patients were obtained from online databases,including TIMER,HCCDB,and Kaplan-Meier Plotter.Then,90 HCC patients who underwent surgical resection at the Affiliated Tumor Hospital of Guangxi Medical University from April 2011 to June 2015 were included,and the expression levels of the PON1 gene in both tumor and adjacent liver tissues were detected.Cox regression analysis was conducted to select pa-rameters with significant prognostic value and construct a prognostic model.Finally,correlation analysis was performed to evaluate immune cell infiltration characteristics.Results The gene level of PON1 was significantly lower in HCC than in adjacent tissues,and low expression of PON1 was associated with poor prognosis of HCC(P<0.05).PON1 mRNA levels,BCLC staging,CNLC staging,T stage,number of microvascular invasions,vascular invasion,and serum AFP were significantly correlated with HCC prognosis(P<0.05).BCLC staging,serum AFP,and PON1 mRNA levels were identified as independent risk factors for the prognosis of HCC patients.The prognostic nomogram based on these three indicators showed good predictive ability for the 1-,2-,and 3-year overall survival rates of HCC patients(C-index=0.757).Im-mune infiltration analysis revealed significant correlations between PON1 and various immune infiltrating cells in HCC(P<0.05).Conclusion Low expression of PON1 can serve as a potential biomarker for poor prognosis in HCC patients.A predic-tive model combining PON1,serum AFP,and BCLC staging can provide individualized prognostic prediction for HCC patients.

PON1prognosishepatocellular carcinomaimmune infiltratesbiomarker

龙小玲、卜昆鹏、曹昭、黄军强、马彩芳、卢秋龙、曾焕、张云、舒宏

展开 >

广西医科大学附属肿瘤医院,广西南宁 530021

广西医科大学第一附属医院,广西南宁 530021

PON1 预后 肝癌 免疫炎症 生物标志物

广西自然科学基金广西壮族自治区高等学校中青年教师科研基础能力提升项目

2023GXNSFAA0260382020KY03034

2024

中国实验诊断学
吉林大学中日联谊医院 上海交通大学医学院附属瑞金医院

中国实验诊断学

CSTPCD
影响因子:1.273
ISSN:1007-4287
年,卷(期):2024.28(4)
  • 22